T-cell Lymphoma Not Otherwise Specified

• CLINICAL_TRIALS trial_result · 2022-10-28
  Clinical Trial Update: Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma [Phase 1, Phase 2]

  Clinical trial update reports safety and efficacy results for Tenalisib (RP6530) in combination with Romidepsin in relapsed/refractory T-cel…